Explore a cutting edge clinical service opportunity with this collection of courses specifically designed to equip pharmacists with the knowledge and skills necessary for the effective management and administration of long-acting injectable medications (LAIs). Course content explores diverse drug profiles, advanced administration techniques, and the strategic implementation of LAI-related services to support the needs of your patients and communities.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
Module 1
1. Describe the signs, symptoms, and diagnostic criteria for schizophrenia and bipolar disorder
2. List the benefits and challenges associated with the use of long-acting injectable (LAI) antipsychotics
3. Compare the FDA-approved LAI antipsychotics, including preparation and administration
4. Discuss the role of the pharmacist in the administration of LAI antipsychotics in the pharmacy setting
5. Formulate a strategy to transition a case-based patient from an oral antipsychotic to a LAI antipsychotic

Module 2
1. Review the various types of injections that may be delivered in pharmacy practice
2. Identify techniques and recommended practices for delivering injectable medications
3. Assess the appropriate injection method based on patient factors, medication characteristics, and safety considerations

Module 3
1. Discuss the opportunities and challenges of developing a LAI service
2. Describe the key components and procedures necessary for implementing a LAI administration service
3. Develop a policy, procedure, and plan for providing LAI administration services
4. Recognize options to expand LAI administration through community partnerships

Katelynn Mayberry, PharmD
Clinical Assistant Professor of Pharmacy Practice
Mercer University College of Pharmacy

Elizabeth Skoy, PharmD, FAPhA
Professor
North Dakota State University

Lindsay McCoy, PharmD, BCPP
Pharmacy Manager
Village Drug Shop at Advantage

Katelynn Mayberry, Elizabeth Skoy, and Lindsay McCoy have no relevant financial relationships with ineligible companies to disclose.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: August 1, 2024
Planned Expiration Date: August 1, 2027

Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.